Molecules and Cells

Cited by CrossRef (46)

  1. Linyan Wang, Haiyun Wang, Dongli Song, Menglin Xu, Michael Liebmen. New strategies for targeting drug combinations to overcome mutation-driven drug resistance. Seminars in Cancer Biology 2017;42:44
    https://doi.org/10.1016/j.semcancer.2016.11.002
  2. Xian Zhang, Qinggong Guo, Jingtao Chen, Zhaohui Chen. Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis. 2015;38:638
    https://doi.org/10.14348/molcells.2015.0037
  3. . miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer Drugs. 2016;39:299
    https://doi.org/10.14348/molcells.2016.2242
  4. Jian Zheng, Xiaobai Liu, Yixue Xue, Wei Gong, Jun Ma, Zhuo Xi, Zhongyou Que, Yunhui Liu. TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway. J Hematol Oncol 2017;10
    https://doi.org/10.1186/s13045-017-0422-2
  5. Tetsuya Idichi, Naohiko Seki, Hiroshi Kurahara, Keiichi Yonemori, Yusaku Osako, Takayuki Arai, Atsushi Okato, Yoshiaki Kita, Takaaki Arigami, Yuko Mataki, Yuko Kijima, Kosei Maemura, Shoji Natsugoe. Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma. Oncotarget 2017;8:53180
    https://doi.org/10.18632/oncotarget.18261
  6. Pengpeng Liu, Rui Zhang, Wenwen Yu, Yingnan Ye, Yanan Cheng, Lei Han, Li Dong, Yongzi Chen, Xiyin Wei, Jinpu Yu. FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells. Biomaterials 2017;149:63
    https://doi.org/10.1016/j.biomaterials.2017.09.030
  7. Jin-Long Hu, Xin-Long Hu, Ai-Ye Guo, Chao-Jie Wang, Yi-Yang Wen, Shun-Dong Cang. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells. Oncotarget 2017;8:49380
    https://doi.org/10.18632/oncotarget.17673
  8. Xi Zhu, Changhao Liu, Jiandang Shi, Zhanwen Zhou, Suoli Chen, Sayed Abdulla Jami. Circular RNA circANKIB1 promotes the progression of osteosarcoma by regulating miR-217/PAX3 axis. Journal of Bone Oncology 2021;27:100347
    https://doi.org/10.1016/j.jbo.2021.100347
  9. Zhong-Ming Huang, Hai Wang, Zhi-Gang Ji. Bladder mesenchymal stromal cell-derived exosomal miRNA-217 modulates bladder cancer cell survival through Hippo-YAP pathway. Inflamm. Res. 2021;70:959
    https://doi.org/10.1007/s00011-021-01494-7
  10. Shuai Zhou, Chao Zhu, Qing Pang, Hui Chun Liu. MicroRNA-217: A regulator of human cancer. Biomedicine & Pharmacotherapy 2021;133:110943
    https://doi.org/10.1016/j.biopha.2020.110943
  11. Jinhua Yan, Guohe Wu, Jianlan Chen, Lifang Xiong, Guoan Chen, Ping Li. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia. CBM 2018;22:73
    https://doi.org/10.3233/CBM-170936
  12. Pingping Liu, Haiyan Yang, Jing Zhang, Xiaozhong Peng, Zhaohui Lu, Weimin Tong, Jie Chen. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Sci Rep 2017;7
    https://doi.org/10.1038/s41598-017-05274-4
  13. Irina Fadejeva, Horst Olschewski, Andelko Hrzenjak. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas. Oncotarget 2017;8:115754
    https://doi.org/10.18632/oncotarget.22975
  14. Gulsen A. Çiftçi, Halide E. Temel, Leyla Yurttaş. Apoptotic Effect of Novel Benzimidazole Derivatives Bearing Pyridyl/Pyrimidinyl Piperazine Moiety. ACAMC 2022;22:1780
    https://doi.org/10.2174/1871520621666210708095110
  15. Yaron Hillman, Niv Mazkereth, Luba Farberov, Noam Shomron, Zvi Fishelson. Regulation of Complement-Dependent Cytotoxicity by MicroRNAs miR-200b, miR-200c, and miR-217. J.I. 2016;196:5156
    https://doi.org/10.4049/jimmunol.1502701
  16. Jie Yan, Fan Yang, Dengyun Wang, Yuan Lu, Li Liu, Zhengjun Wang. MicroRNA-217 modulates inflammation, oxidative stress, and lung injury in septic mice via SIRT1. Free Radical Research 2021;55:1
    https://doi.org/10.1080/10715762.2020.1852234
  17. Srinivasulu Yerukala Sathipati, Shinn-Ying Ho. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles. Sci Rep 2017;7
    https://doi.org/10.1038/s41598-017-07739-y
  18. Abbas Navabi, Bahman Akbari, Mohammad Abdalsamadi, SeyedSaeid Naseri. The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance. Life Sciences 2022;296:120437
    https://doi.org/10.1016/j.lfs.2022.120437
  19. Nan Zhang, Canrong Lu, Lin Chen. miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer. 2016;12:4589
    https://doi.org/10.3892/ol.2016.5249
  20. Hongxi Chen, Zhipeng Zhang, Yebin Lu, Kun Song, Xiwu Liu, Fada Xia, Weijia Sun. Downregulation of ULK 1 by micro RNA ‐372 inhibits the survival of human pancreatic adenocarcinoma cells . Cancer Sci 2017;108:1811
    https://doi.org/10.1111/cas.13315
  21. Xiaoying Li, XueLian Li, Yangwu Ren, Zhihua Yin, Xiaowei Quan, Xiaoxia Xue, Baosen Zhou. Polymorphisms of rs1347093 and rs1397529 are associated with lung cancer risk in northeast Chinese population. Oncotarget 2017;8:94862
    https://doi.org/10.18632/oncotarget.22030
  22. Yanfang Li, Liping Fei, Junli Wang, Qingying Niu. Inhibition of miR-217 Protects Against Myocardial Ischemia–Reperfusion Injury Through Inactivating NF-κB and MAPK Pathways. Cardiovasc Eng Tech 2020;11:219
    https://doi.org/10.1007/s13239-019-00452-z
  23. Bernhard Biersack. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs. Non-coding RNA Research 2017;2:1
    https://doi.org/10.1016/j.ncrna.2016.10.001
  24. Shaila A. Shetu, Debasish Bandyopadhyay. Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies. IJMS 2022;23:3706
    https://doi.org/10.3390/ijms23073706
  25. Mao Zhang, Min Li, Na Li, Zilang Zhang, Ning Liu, Xiaoyu Han, Qincheng Liu, Caixian Liao. miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma. 2017;37:1772
    https://doi.org/10.3892/or.2017.5401
  26. Agata Dutkowska, Adam Antczak, Daria Domańska-Senderowska, Ewa Brzeziańska-Lasota. Expression of selected miRNA, RARβ and FHIT genes in BALf of squamous cell lung cancer (squamous-cell carcinoma, SCC) patients: a pilot study. Mol Biol Rep 2019;46:6593
    https://doi.org/10.1007/s11033-019-05057-2
  27. Weiyi Jiang, Tingting Xia, Cun Liu, Jie Li, Wenfeng Zhang, Changgang Sun. Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of Cancer. Front. Oncol. 2021;11
    https://doi.org/10.3389/fonc.2021.705903
  28. Zhong-Yi Yan, Zhi-Qing Luo, Lai-Jian Zhang, Jia Li, Jia-Qiang Liu. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma. J. Cell. Physiol. 2017;232:2178
    https://doi.org/10.1002/jcp.25728
  29. Shufeng Duan, Xuecai Dong, Jing Hai, Jinghong Jiang, Wenxiang Wang, Jing Yang, Wei Zhang, Caixia Chen. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2. Biomedicine & Pharmacotherapy 2018;107:712
    https://doi.org/10.1016/j.biopha.2018.08.044
  30. Concetta Panebianco, Nadia Trivieri, Annacandida Villani, Fulvia Terracciano, Tiziana Pia Latiano, Adele Potenza, Francesco Perri, Elena Binda, Valerio Pazienza. Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels. Biomolecules 2021;11:639
    https://doi.org/10.3390/biom11050639
  31. Lu Lu, Fei Luo, Yi Liu, Xinlu Liu, Le Shi, Xiaolin Lu, Qizhan Liu. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial–mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract. Toxicology and Applied Pharmacology 2015;289:276
    https://doi.org/10.1016/j.taap.2015.09.016
  32. Akhil Srivastava, Narsireddy Amreddy, Rebaz Ahmed, Mohammed A. Razaq, Katherine Moxley, Rheal Towner, Yan D. Zhao, Allison Gillaspy, Ali S. Khan, Anupama Munshi, Rajagopal Ramesh. Diagnostic and Therapeutic Applications of Exosomes in Cancer. 2015.
    https://doi.org/10.1016/B978-0-12-812774-2.00008-0
  33. Youngmi Kim, Hyuna Kim, Deokbum Park, Minho Han, Hansoo Lee, Yun Sil Lee, Jongseon Choe, Young Myeong Kim, Dooil Jeoung. miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2. Oncotarget 2016;7:10297
    https://doi.org/10.18632/oncotarget.7185
  34. Shaoxuan He, Zhihua Wang, Hao Tang, Junjie Dong, Yongzhou Qu, Jia Lv. MiR-217 Inhibits Proliferation, Migration, and Invasion by TargetingSIRT1in Osteosarcoma. Cancer Biotherapy and Radiopharmaceuticals 2019;34:264
    https://doi.org/10.1089/cbr.2017.2394
  35. Xiaomeng Jiang, Menglin Jiang, Shuhua Guo, Pengpeng Cai, Wei Wang, Yi Li.

    Promotion of miR-221-5p on the Sensitivity of Gastric Cancer Cells to Cisplatin and Its Effects on Cell Proliferation and Apoptosis by Regulating DDR1

    . OTT 2020;Volume 13:2333
    https://doi.org/10.2147/OTT.S232953
  36. Mohammad Tobeiha, Ali Rajabi, Arash Raisi, Mahshad Mohajeri, Soheil Mohammadi Yazdi, Amirhossein Davoodvandi, Fatemeh Aslanbeigi, MohamadSadegh Vaziri, Michael R. Hamblin, Hamed Mirzaei. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms. Biomedicine & Pharmacotherapy 2021;144:112257
    https://doi.org/10.1016/j.biopha.2021.112257
  37. Maria Konoshenko, Yuriy Lansukhay, Sergey Krasilnikov, Pavel Laktionov. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin. IJMS 2022;23:7594
    https://doi.org/10.3390/ijms23147594
  38. Amir Abbas Hamidi, Malihe Zangoue, Daniel Kashani, Amir Sadra Zangouei, Hamid Reza Rahimi, Mohammad Reza Abbaszadegan, Meysam Moghbeli. MicroRNA-217: a therapeutic and diagnostic tumor marker. Expert Review of Molecular Diagnostics 2022;22:61
    https://doi.org/10.1080/14737159.2022.2017284
  39. Xin-Shuang Yu, Juan Du, Yu-Jun Fan, Feng-Jun Liu, Li-Li Cao, Ning Liang, De-Guo Xu, Jian-Dong Zhang. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. Oncotarget 2016;7:76827
    https://doi.org/10.18632/oncotarget.12718
  40. Chen Wu, Bin Xu, You Zhou, Mei Ji, Dachuan Zhang, Jingting Jiang, Changping Wu. Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients. Oncotarget 2016;7:85876
    https://doi.org/10.18632/oncotarget.13042
  41. Madhuri Dutta, Biswajit Das, Debasish Mohapatra, Padmanava Behera, Shantibhusan Senapati, Anasuya Roychowdhury. MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2. Life Sciences 2022;301:120592
    https://doi.org/10.1016/j.lfs.2022.120592
  42. Hongyan Zhang, Feng Liang, Fei Wang, Qianru Xu, Yuxuan Qiu, Xin Lu, Lin Jiang, Kaiyu Jian. miR-148-3p inhibits gastric cancer cell malignant phenotypes and chemotherapy resistance by targeting Bcl2. Bioengineered 2021
    https://doi.org/10.1080/21655979.2021.2005742
  43. Hongxia Xiao, Zhen Liu. Effects of microRNA‑217 on high glucose‑induced inflammation and apoptosis of human retinal pigment epithelial cells (ARPE‑19) and its underlying mechanism. Mol Med Report 2019
    https://doi.org/10.3892/mmr.2019.10778
  44. Yongliang Li, Mi Tian, Dongqing Zhang, Yifei Zhuang, Zhimin Li, Shenqi Xie, Keyu Sun. Long Non-Coding RNA Myosin Light Chain Kinase Antisense 1 Plays an Oncogenic Role in Gallbladder Carcinoma by Promoting Chemoresistance and Proliferation. CMAR 2021;Volume 13:6219
    https://doi.org/10.2147/CMAR.S323759
  45. Xiaoyang Li, Jacson K. Shen, Francis J. Hornicek, Tao Xiao, Zhenfeng Duan. Noncoding RNA in drug resistant sarcoma. Oncotarget 2017;8:69086
    https://doi.org/10.18632/oncotarget.19029
  46. Yi Xiao, Taoran Deng, Changliang Su, Zhen Shang. MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. 2017;13:4986
    https://doi.org/10.3892/ol.2017.6076